review of literature on clinical pancreatology - The Pancreapedia

More documents

Recommendations

Info

ITNPintrathecal narcotics pumpJCGAIPJapanese clinical guidelines for autoimmune pancreatitisKOCK homology domain containing protein overexpresssed incancerL-aspL-asparaginaseLCMlaser-capture microdissectionLDLlow-density lipoproteinLEBSlow-coherence enhanced backscatteringLNlymph nodeLNMlymph node metastasisLNRlymph node ratioLPlaparoscopic distal pancreatectomyLPCliver perfusion chemotherapyLPSPlymphoplasmacytic sclerosing pancreatitisMABPmild acute biliary pancreatitisMCNmucinous cystic neoplasmMDCTmultidetector computer tomographyM3DDmaximum 3-dimensional diameterMD-IPMNmain duct pancreatic intraductal papillary-mucinous neoplasmmDNAmitochondrial DNAMEN-1 multiple endocrine neoplasia type 1MEN-2 multiple endocrine neoplasia syndrome type 2mFOLFOX 5-fluorouracil (5-FU), folinic acid, and oxaliplatinmFOLFOX.3 5-fluorouracil (5-FU), folinic acid, and irinotecanMIBGmetaiodobenzylguanidineMI-IPMCminimally invasive intraductal papillary mucinous neoplasmMm-MASTa score measuring alcohol addictionMMPmatrix metalloproteinaseMMRmismatch repairMnd-QDmanganese-doped quantum dotsMOFmultiple organMPDmain pancreatic ductMPRmultiplanar reformationMRCPmagnetic resonance cholangiopancreatographyMRImagnetic resonance imagemRNAmessenger RNAMSImicrosatellite instabilityMSTmedian survival timeMT-SP1matriptaseMTT3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromideNACRTneoadjuvant chemoradiation therapyNETneuroendocrine tumorsNEUROD1 neurogenic differentiation 1NEUROG3 neurogenin 3NF-kappaB nuclear factor-kappaBNGFnerve growth factorNIRnear-infraredNOFnon organ failureNOMnonoperative managementNOTESnatural orifice transluminal endoscopic surgeryNOxexcretion <strong>of</strong> nitric oxideNPnecrotizing pancreatitisNPMnucleophosminNPVnegative predictive valuesNSEneuron-specific enolase
ODPopen distal pancreatectomyOForgan failure25(OH)D25-hydroxyvitamin DORodds ratiosOSoverall survivalPACpancreatic adenocarcinomaPAFplatelet-activating factorPAI-1 plasminogen activator inhibitor type 1PAMprediction analysis for microarraysPanINpancreatic intraepithelial neoplasiaPAP-1 pancreatitis-associated protein 1PBPplasminogen-binding proteinPCpancreatic cancerPCDpercutaneous catheter drainagePCIprotein C inhibitorPDperitoneal dialysisPDpancreatoduodenectomyPDApancreatic ductal adenocarcinomasPDACpancreatic ductal adenocarcinomaPDI pancreatic ductal injury .PDX1 pancreatic duodenal homeobox factor 1PECApancreatic endocrine carcinomasPEGpolyethylene glycolsPENpancreatic endocrine neoplasmPETpancreatic endocrine tumorPETpositron emission tomographyPFprogression-freePFCpancreatic fluid collectionsPGpancreaticogastrostomyPGF1-alpha prostaglandin F1-alphaP4H-betaprolyl 4-hydroxylase-betaPIpancreatic injuryPJpancreaticojejunostomyPJSPeutz-Jeghers syndromepNETpancreatic neuroendocrine tumorsp-NPMphosphorylated nucleophosminPODpostoperative daysPOPFpostoperative pancreatic fistulaPOU3F4 POU class 3 homeobox 4PPpancreatic polypeptidePPARGperoxisome proliferator-activated receptor-gammaPPFpancreaticopleural fistulaPPHpostpancreatectomy hemorrhagePPPDpylorus-preserving pancreatoduodenectomyPRRTpeptide receptor radionuclide therapyPPVpositive predictive valuesPRprogesterone receptorPSCpancreatic stellate cellsPSCAprostate stem cell antigenPTCHmembrane receptor patchedPTFEpolytetrafluoroethylenePVRportal vein reconstructionQDquantum dotsQLQquality <strong>of</strong> lifeQoLquality <strong>of</strong> life
Page 1 and 2: REVIEW OF LITERATURE ONCLINICAL PAN
Page 3 and 4: ABBREVIATIONAAPacute alcoholicABPac
Page 5: FMF AIPfocal mass-forming autoimmun
Page 9 and 10: USUTDTVESDVTEZESWHOXIAPUnited State
Page 11 and 12: Ectopic pancreasCircumportal annula
Page 13 and 14: SymptomsEndocopic ultrasography (EU
Page 15 and 16: HSP27HuRIGF-1 receptorIntegrinesInt
Page 17 and 18: HemodialysisSerous cystadenomasSero
Page 19 and 20: CRPC-reactive proteinCRTchemoradiot
Page 21 and 22: ITNPintrathecal narcotics pumpJCGAI
Page 23 and 24: QSRquantitative systematic
Page 25 and 26: PANCREATIC HISTORYEarly conceptsPan
Page 27 and 28: derived from broadly Harveian anato
Page 29 and 30: acute appendicitis, intestinal obst
Page 31 and 32: dogma and its implied presence <str
Page 33 and 34: In the late 19th century, explorato
Page 35 and 36: performed. In 1880, Carl Thiersch <
Page 37 and 38: cancer was reported by Nestor Dimit
Page 39 and 40: Modern pancreatic historyHoward Reb
Page 41 and 42: PANCREATIC DEVELOPMENT, EMBRYOLOGY
Page 43 and 44: preparations. They were also employ
Page 45 and 46: pancreas can be diagnosed without t
Page 47 and 48: PANCREATIC PHYSIOLOGYSphincter <str
Page 49 and 50: acid profile and d
Page 51 and 52: hormones. The roles of</str
Page 53 and 54: ACUTE PANCREATITISAcute pancreatiti
Page 55 and 56: necrosis or a severe course, and lo
Page 57 and 58:
of 245 cases <stro
Page 59 and 60:
plasty of the mino
Page 61 and 62:
no significant difference. The stro
Page 63 and 64:
Urinary trypsinogen-2There is not a
Page 65 and 66:
groups. None of th
Page 67 and 68:
evaluated the presence or absence <
Page 69 and 70:
adical, etc, further studies are st
Page 71 and 72:
Precut at sphincterotomyPrecut is p
Page 73 and 74:
indications [204].Hypercalcemia-ind
Page 75 and 76:
endoscopic retrograde cholangiopanc
Page 77 and 78:
(before ERCP), serum TAP was detect
Page 79 and 80:
concentration and clinical symptoms
Page 81 and 82:
However, the recipients of<
Page 83 and 84:
less safe for predominantly cephali
Page 85 and 86:
increased mortality. Mortality in p
Page 87 and 88:
Epidemiology and demographyChinaCHR
Page 89 and 90:
for the first time the significance
Page 91 and 92:
endoscopic ultrasound accurately de
Page 93 and 94:
possible to at least reduce relapse
Page 95 and 96:
etiologies have been proposed and a
Page 97 and 98:
patients, can be performed with mod
Page 99 and 100:
negative binomial model. One hundre
Page 101 and 102:
Halofuginone did n
Page 103 and 104:
years, the risk of
Page 105 and 106:
patients with a proven exocrine pan
Page 107 and 108:
high-risk patients [296].Cystic fib
Page 109 and 110:
TNF-alpha promoter were performed.
Page 111 and 112:
were validated in another series <s
Page 113 and 114:
vascular invasion (14/15). Abnormal
Page 115 and 116:
and other lymph nodes, salivary gla
Page 117 and 118:
HEREDITARY PANCREATITISPatients wit
Page 119 and 120:
Classification of
Page 121 and 122:
historically, but recent life-style
Page 123 and 124:
carcinogen exposure with cancer ris
Page 125 and 126:
the risk of pancre
Page 127 and 128:
conducted a cohort analysis <strong
Page 129 and 130:
emain to be solved in screening for
Page 131 and 132:
considered for women with Lynch syn
Page 133 and 134:
Annexin A5Protein misfolding is a c
Page 135 and 136:
CTNNB1To use fluorescence in situ h
Page 137 and 138:
expression was not associated with
Page 139 and 140:
(ECM) are not fully understood. In
Page 141 and 142:
lines. However, the role of
Page 143 and 144:
andomized to high-dose vitamin A, t
Page 145 and 146:
Synuclein-gammaPerineural invasion
Page 147 and 148:
interventions. Cancer nests were ma
Page 149 and 150:
the optimal combination of<
Page 151 and 152:
which is essential in tumor and nod
Page 153 and 154:
provide conclusive evidence for the
Page 155 and 156:
MD-CT is suitable for evaluating tu
Page 157 and 158:
approved study and imaged during sh
Page 159 and 160:
Quantum dotsIt was reported the suc
Page 161 and 162:
clearly have a very high incidence
Page 163 and 164:
patients for operation and when cou
Page 165 and 166:
demonstrated using the confocal mic
Page 167 and 168:
cancer [468].To evaluate pancreatic
Page 169 and 170:
pancreaticoduodenectomy (PD). The s
Page 171 and 172:
safe option as an interposition gra
Page 173 and 174:
a curative surgery, while double-by
Page 175 and 176:
%), pseudocyst (3 %), and trauma (3
Page 177 and 178:
procedure is failing to progress la
Page 179 and 180:
Glucos metabolism after pancreatect
Page 181 and 182:
Quality of lifeOne
Page 183 and 184:
was observed in the NACRT group. Th
Page 185 and 186:
interval 0.80 to 0.96]. On subgroup
Page 187 and 188:
ate in patients with pancreatic can
Page 189 and 190:
median survival time was 7 versus 7
Page 191 and 192:
and the endoscopic ultrasound-guide
Page 193 and 194:
local recurrence of1.5 cm (odds ratio 2.4), and
Page 199 and 200:
adenocarcinoma must be addressed at
Page 201 and 202:
Molecular biologyCD44v6The purpose
Page 203 and 204:
IPMN were studied. Two-dimensional
Page 205 and 206:
the NT-IPMN-Br group. Eleven patien
Page 207 and 208:
metastatic neoplasms showing cystic
Page 209 and 210:
Solid pseudopapillary neoplasms <st
Page 211 and 212:
The tumor cells were negative for p
Page 213 and 214:
Duodenal tumorsColorectal polyposis
Page 215 and 216:
Colorectal carcinomaPancreatic meta
Page 217 and 218:
It was described a case of<
Page 219 and 220:
evaluation. The purpose of<
Page 221 and 222:
perforation of a p
Page 223 and 224:
the 28 had pancreatic duct injury <
Page 225 and 226:
ENDOCRINE PANCREATIC TUMORSHistoryA
Page 227 and 228:
25-111 pg/mL). Mean Hemoglobin A1C
Page 229 and 230:
clinical features, misdiagnosis occ
Page 231 and 232:
achieved in selected cases by tissu
Page 233 and 234:
Overall survivalPancreatic neuroend
Page 235 and 236:
REFERENCES001. Metter CC. History <
Page 237 and 238:
044. Fitz RH. The symptomatology an
Page 239 and 240:
089. McClusky DA, Skandalakis LJ, C
Page 241 and 242:
126. Toouli J. Sphincter of
Page 243 and 244:
162. Deshpande AV, Thomas G, Shun A
Page 245 and 246:
196. Park JH, Lee TH, Cheon SL, Sun
Page 247 and 248:
226. Botoi G, Andercou A. Early and
Page 249 and 250:
260. Nakamura H, Morifuji M, Muraka
Page 251 and 252:
292. Borak GD, Romagnuolo J, Alsola
Page 253 and 254:
324. Oh HC, Kim MH, Choi KS, Moon S
Page 255 and 256:
358. Koornstra JJ, Mourits MJ, Sijm
Page 257 and 258:
391. Chen JY, Amos CI, Merriman KW,
Page 259 and 260:
421. Horwhat JD, Gerke H, Acosta RD
Page 261 and 262:
451. Zamboni G, Capelli P, Scarpa A
Page 263 and 264:
483. Rosa F, Pacelli F, Papa V, Tor
Page 265 and 266:
517. Isayama H, Nakai Y, Togawa O,
Page 267 and 268:
545. Pino MS, Milella M, Gelibter A
Page 269 and 270:
576. Tanno S, Sasajima J, Koizumi K
Page 271 and 272:
605. Ayadi L, Ellouze S, Khabir A,
Page 273 and 274:
637. Nagar AM, Raut AA, Morani AC,
Page 275 and 276:
670. Lejonklou M, Edfeldt K, Johans
show all

review of literature on clinical pancreatology - The Pancreapedia

Create successful ePaper yourself

Delete template?

Save as template?